These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33483585)

  • 1. The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancer.
    Lage-Vickers S; Bizzotto J; Valacco MP; Sanchis P; Nemirovsky S; Labanca E; Scorticati C; Mazza O; Mitrofanova A; Navone N; Vazquez E; Cotignola J; Gueron G
    Commun Biol; 2021 Jan; 4(1):103. PubMed ID: 33483585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia.
    Kawahara R; Recuero S; Nogueira FCS; Domont GB; Leite KRM; Srougi M; Thaysen-Andersen M; Palmisano G
    Proteomics; 2019 Nov; 19(21-22):e1900174. PubMed ID: 31576646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
    Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
    Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients.
    Caruso RP; Levinson B; Melamed J; Wieczorek R; Taneja S; Polsky D; Chang C; Zeleniuch-Jacquotte A; Salnikow K; Yee H; Costa M; Osman I
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):222-7. PubMed ID: 14734473
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kim YH; Byun YJ; Kim WT; Jeong P; Yan C; Kang HW; Kim YJ; Lee SC; Moon SK; Choi YH; Yun SJ; Kim WJ
    J Korean Med Sci; 2018 Nov; 33(47):e303. PubMed ID: 30450027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma].
    Lai JS; Xia Q; Zhang XB; Zhao GP; Xu SL; Zheng DS
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):476-8. PubMed ID: 15555337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma.
    Alaiya AA; Al-Mohanna M; Aslam M; Shinwari Z; Al-Mansouri L; Al-Rodayan M; Al-Eid M; Ahmad I; Hanash K; Tulbah A; Bin Mahfooz A; Adra C
    Int J Oncol; 2011 Apr; 38(4):1047-57. PubMed ID: 21305254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of miRNA-153 on PTEN expression in prostatic adenocarcinoma.
    Aboushousha T; El-Nahas EI; El-Hindawi A; Elwi D; El-Ganzouri H; Hammam O; Magdy M; Helal NS
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6834-6843. PubMed ID: 34859846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of PARP-1 and its active polymer PAR in prostate cancer and benign prostatic hyperplasia in Chinese patients.
    Wu W; Zhu H; Liang Y; Kong Z; Duan X; Li S; Zhao Z; Yang D; Zeng G
    Int Urol Nephrol; 2014 Jul; 46(7):1345-9. PubMed ID: 24436031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
    Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
    Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer.
    Menon R; Deng M; Rüenauver K; Queisser A; Peifer M; Pfeifer M; Offermann A; Boehm D; Vogel W; Scheble V; Fend F; Kristiansen G; Wernert N; Oberbeckmann N; Biskup S; Rubin MA; Adler D; Perner S
    J Pathol; 2013 Dec; 231(4):505-16. PubMed ID: 24114522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
    Luna-Coronell JA; Vierlinger K; Gamperl M; Hofbauer J; Berger I; Weinhäusel A
    Proteomics; 2016 Apr; 16(8):1204-14. PubMed ID: 27089054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.
    Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
    J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of YWHAZ expression in localized prostate cancer.
    Rüenauver K; Menon R; Svensson MA; Carlsson J; Vogel W; Andrén O; Nowak M; Perner S
    Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):310-4. PubMed ID: 25156059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.
    Li Y; Pan P; Qiao P; Liu R
    Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
    Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
    Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin receptor as a novel imaging target for prostatic neoplasms.
    Lu C; McFarland MS; Nesbitt RL; Williams AK; Chan S; Gomez-Lemus J; Autran-Gomez AM; Al-Zahrani A; Chin JL; Izawa JI; Luyt LG; Lewis JD
    Prostate; 2012 Jun; 72(8):825-33. PubMed ID: 21919027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.